NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 6, 2025 — Sigyn Therapeutics introduces CardioDialysis™ to treat cardiovascular disease in dialysis patients. The device targets multiple inflammatory pathways and could reduce major cardiac events by leveraging existing dialysis infrastructure.
November 6, 2025 — Lantern Pharma announces Q3 2025 results webcast discussing AI-driven cancer therapies. Learn about RADR platform progress, clinical trials, and $15B market potential for oncology treatments.
November 6, 2025 — Annovis Bio announces all 84 U.S. sites for its Phase 3 Alzheimer's trial are now active and enrolling patients, with data expected in 2026 for experimental drug buntanetap.
November 6, 2025 — HeartBeam submits 12-lead ECG synthesis software to FDA for 510(k) clearance. Breakthrough cable-free technology aims to transform atrial fibrillation detection and cardiac arrhythmia assessment worldwide.
November 6, 2025 — New research shows CNS cancer patients experience significant neurocognitive decline from tumors and treatments. CNS Pharmaceuticals and other biotech firms must address cognitive effects in therapy development.
November 6, 2025 — Shifa Therapy partners with mosques to provide culturally sensitive Muslim mental health services across US, Canada & UK. Breaking stigma through faith-aligned therapy access.
November 6, 2025 — The Moses Firm, an Atlanta medical malpractice law firm, specializes in catastrophic cases including birth injuries and misdiagnosis. Free consultations available at (404) 721-1050.
November 6, 2025 — Dr. Barbara Sharief launches The BBS Glow Collection, a medical-grade anti-aging skincare line with 8 products. Developed with 34 years of clinical expertise for natural aging solutions.
November 6, 2025 — Las Vegas transforms into luxury medical tourism hub as Signature Plastic Surgery partners with resorts. Dr. Himansu Shah leads board-certified cosmetic procedures with luxury recovery experiences.
November 5, 2025 — NanoViricides announces 2025 shareholder meeting while advancing broad-spectrum antiviral drugs. Clinical-stage company developing NV-387 for RSV, COVID, influenza treatments using innovative nanoviricide technology.
November 5, 2025 — HeartBeam receives Buy rating and $4 price target from Roth Capital for breakthrough 12-lead ECG technology. FDA clearance expected by 2025 for portable cardiac monitoring device.
November 5, 2025 — MIT and Harvard researchers develop enhanced natural killer cells for cancer immunotherapy. Breakthrough could lead to off-the-shelf treatments revolutionizing cancer care. Early results show effectiveness in fighting tumors.
November 5, 2025 — Ocumetics announces breakthrough results in human trials of accommodating intraocular lens, showing 20/32 to 20/25 vision restoration in cataract patients within one month post-surgery.
November 5, 2025 — American Heart Association educates HBCU football fans about hypertrophic cardiomyopathy, the leading cause of sudden cardiac death in young athletes, and teaches life-saving Hands-Only CPR techniques.
November 5, 2025 — Austin chiropractor Dr. Matt Delgado prescribes Time Out Rx to combat burnout through his Core 4 strategy. Learn how strategic pauses can transform health and productivity.
November 5, 2025 — NeuroOne Medical Technologies receives 180-day Nasdaq extension to regain compliance with minimum $1 stock price requirement. Medical tech company developing neurological disorder treatments gets until May 2026.
November 5, 2025 — A Place At Home – North Austin wins Best of Round Rock Award for second year. Learn about their senior home care, dementia programs & veteran support services in Williamson & Travis Counties.
November 5, 2025 — SunKnowledge Inc. revolutionizes healthcare with specialized virtual medical assistant services, offering 80% cost savings and 95% efficiency improvements for medical practices nationwide.
November 5, 2025 — Avignon's Centre for Education challenges traditional university accreditation, advocating for pluralism in recognizing informal higher education models while maintaining academic rigor and cultural responsiveness.
November 5, 2025 — BioUtah announces 2025 Life Sciences Awards honoring innovators in HIV research, cancer therapy, medical devices. Summit November 12 recognizes Utah's healthcare leadership.